Publications by authors named "Shao-Jia Mou"
Article Synopsis
- Gastric cancer is difficult to treat and has a poor prognosis, with the study focusing on ephrin-B2 as a potential prognostic factor and therapeutic target.
- The research found that ephrin-B2 levels were significantly higher in gastric cancer patients compared to healthy individuals, and its expression correlated with larger tumor size, metastasis, and advanced stages of cancer.
- High levels of ephrin-B2 were linked to shorter survival rates, while reducing ephrin-B2 expression in cancer cells decreased their viability and triggered cell death, highlighting its role as an oncogene and promising target for treatment.
